UNIQUE EXPERTISE
Headquartered in Reykjavik, Iceland, deCODE is a global leader in analyzing and understanding the human genome. Using our unique expertise and population resources, deCODE has discovered key genetic risk factors for dozens of common diseases ranging from cardiovascular disease to cancer.
UNIQUE CAPABILITIES
We operate the most productive human gene discovery engine in the world, employing our discoveries to identify genetic variations associated with human disease.
OUR PUBLICATIONS
We regularly publish our discoveries in major, peer-reviewed journals, enabling others to further validate and expand upon our findings.
NEWS
deCODE Lauds Federal Legislation to Ban Discrimination on the Basis of Genetic Information
Reykjavik, ICELAND, April 25, 2008 – deCODE genetics (Nasdaq:DCGN) today expressed its enthusiastic support for the Genetic Information Non-discrimination Act (GINA), a bill that, many years in the making, is now moving swiftly through Congress and is expected to be...
deCODE Identifies Novel Regions of the Genome that Affect Normal Adult Height
April 6, 2008 – Scientists at deCODE genetics have identified 27 regions in the human genome that affect adult height. These variants, which are published today in the online edition of Nature Genetics, together explain an estimated 4% percent of the normal population...
Award by the American Society of Human Genetics
At its Annual meeting in October 2017 in Orlando, the American Society of Human Genetics (ASHG), presented Dr. Kári Stefánsson, founder and CEO of deCODE genetics, with the William Allan Award. The award, the top prize given by the society, recognizes a scientist for substantial and far-reaching scientific contributions to human genetics. The ASHG has distributed video footage from the award ceremony. The introduction is given by Professor Mark Daly of Harvard University.